These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7030040

  • 1. Effects of prostacyclin on systemic and coronary hemodynamics in the dog.
    Mehta J, Nichols WW, Mehta P, Pepine C, Conti CR.
    Am Heart J; 1981 Nov; 102(5):835-40. PubMed ID: 7030040
    [Abstract] [Full Text] [Related]

  • 2. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ, Chapple DJ, Hughes R, Moncada S, Vane JR.
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [Abstract] [Full Text] [Related]

  • 3. Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium.
    Einzig S, Sotomora R, Rao GH, Gerrard JM, Foker JE, White JG.
    Prostaglandins Med; 1980 Sep; 5(3):209-19. PubMed ID: 6997909
    [Abstract] [Full Text] [Related]

  • 4. Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts.
    Scholtholt J, Birringer H, Fiedler VB, Schölkens B.
    Basic Res Cardiol; 1981 Sep; 76(3):313-27. PubMed ID: 7023464
    [Abstract] [Full Text] [Related]

  • 5. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs.
    Panzenbeck MJ, Hintze TH, Kaley G.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239
    [Abstract] [Full Text] [Related]

  • 6. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA, Primm RK, Woosley RL, Oates JA, Hammon JW.
    J Cardiovasc Pharmacol; 1982 Mar; 4(5):765-9. PubMed ID: 6182407
    [Abstract] [Full Text] [Related]

  • 7. The influence of prostacyclin on hemodynamic and coronary blood flow in dogs.
    Teesalu R, Kòrgevee A.
    Biomed Biochim Acta; 1988 Mar; 47(10-11):S56-9. PubMed ID: 3073770
    [Abstract] [Full Text] [Related]

  • 8. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
    Fiedler VB, Mardin M.
    Basic Res Cardiol; 1986 Mar; 81(1):40-53. PubMed ID: 3521579
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2.
    Kadowitz PJ, Chapnick BM, Feigen LP, Hyman AL, Nelson PK, Spannhake EW.
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Sep; 45(3):408-13. PubMed ID: 359514
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
    Firth BG, Winniford MD, Campbell WB, Hillis LD.
    Am J Cardiol; 1983 Sep 01; 52(5):439-43. PubMed ID: 6351580
    [Abstract] [Full Text] [Related]

  • 11. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL, Kadowitz PJ, Lands WE, Crawford CG, Fried J, Barton J.
    Proc Natl Acad Sci U S A; 1978 Jul 01; 75(7):3522-6. PubMed ID: 356056
    [Abstract] [Full Text] [Related]

  • 12. Differential sensitivity of regional vascular beds in the dog to low-dose prostacyclin infusion.
    Einzig S, Rao GH, White JG.
    Can J Physiol Pharmacol; 1980 Aug 01; 58(8):940-6. PubMed ID: 7013952
    [Abstract] [Full Text] [Related]

  • 13. The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.
    Dix RK, Kelliher GJ, Jurkiewicz N, Lawrence T.
    Prostaglandins Med; 1979 Sep 01; 3(3):173-84. PubMed ID: 399533
    [Abstract] [Full Text] [Related]

  • 14. Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart.
    Kowey PR, Verrier RL, Lown B.
    Eur J Pharmacol; 1982 May 07; 80(1):83-91. PubMed ID: 7047179
    [Abstract] [Full Text] [Related]

  • 15. Systemic and coronary hemodynamic effects of prostacyclin and nitroprusside in conscious dogs.
    Dinerman J, Mehta JL, Nichols WW.
    J Cardiovasc Pharmacol; 1988 Oct 07; 12(4):492-6. PubMed ID: 2465452
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
    Kubo K, Kobayashi T, Yoshimura K, Fukushima M, Handa K, Kusama S, Sakai A, Ueda G.
    Jpn Circ J; 1982 Dec 07; 46(12):1292-304. PubMed ID: 6754986
    [Abstract] [Full Text] [Related]

  • 17. Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs.
    Zhao G, Xu X, Ochoa M, Shen W, Hintze TH.
    Cardiovasc Res; 1996 Nov 07; 32(5):940-8. PubMed ID: 8944825
    [Abstract] [Full Text] [Related]

  • 18. Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin).
    Aiken JW, Shebuski RJ.
    Prostaglandins; 1980 Apr 07; 19(4):629-43. PubMed ID: 6992235
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of leukotriene D4-induced coronary vasoconstriction by leukotriene antagonists in the anesthetized dog.
    Kopia GA, Valocik RE, Torphy TJ, Cieslinksi LB, Sarau HM, Foley JJ, Wasserman MA.
    J Pharmacol Exp Ther; 1987 Apr 07; 241(1):174-80. PubMed ID: 2437287
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs.
    Pagel PS, Hettrick DA, Lowe D, Gowrie PW, Kersten JR, Bosnjak ZJ, Warltier DC.
    Eur J Pharmacol; 1998 May 08; 348(2-3):213-21. PubMed ID: 9652336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.